Journal of Physical Therapy Science
Online ISSN : 2187-5626
Print ISSN : 0915-5287
ISSN-L : 0915-5287
Original Article
Is the SPARTACUS 15-15 test an accurate proxy for the assessment and tracking of maximal aerobic capacities in adolescents with obesity?
Alicia FillonMaud MiguetGrace O’MalleyMarie-Eve MathieuJulie MasurierValérie JulianCharlotte CardenouxBruno PereiraOlivier ReyMartine DuclosYves BoirieDavid Thivel
Author information
JOURNAL OPEN ACCESS

2020 Volume 32 Issue 4 Pages 281-287

Details
Abstract

[Purpose] While there is a need for reliable field tests for the evaluation of physical fitness in pediatric obesity, the present work i) evaluates the validity of the Spartacus 15-15 test in indirectly assessing maximal aerobic capacity in adolescents with obesity and ii) evaluates its sensibility to weight loss. [Participants and Methods] Fifty-five 11–16 year-old adolescents with obesity (Tanner 3–4) were enrolled in a 12-week weight-management intervention. Maximal Aerobic fitness (VO2peak test + Spartacus test) and body composition (Dual X-ray absorptiometry) were assessed at baseline and after 12 weeks. [Results] Moderate correlations were found at baseline between VO2peak (2,231.90 ± 465.6 mL/min) and Spartacus stage (6.83 ± 1.8 stage, r=0.52; p≤0.05), speed (12.85 ± 1.8 km/h, r=0.52 ; p≤0.05) and time (20.6 ± 5.4 min; r=0.50; p≤0.05). The intervention favored significant improvements for VO2peak, Spartacus Rate of Perceived Exertion final stage, maximal speed and time. Change over time in VO2peak and Spartacus variables were not correlated. [Conclusion] The Spartacus test can be used as a proxy for VO2peak at baseline and can be used to estimate VO2peak using the proposed equation. The Spartacus 15-15 test might be a better indicator for changes in functional capacity than an indicator of VO2peak changes in youth with obesity.

Content from these authors
© 2020 by the Society of Physical Therapy Science. Published by IPEC Inc.

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top